Resources

Liver Disease Information

In Your Area


Contact Us

American Liver Foundation
39 Broadway, Suite 2700
New York, New York 10006

212-668-1000 Tel
212-483-8179 Fax

Home > Healthcare Professionals > DSA Award Recipients

Distinguished Scientific Achievement Award


2014 Distinguished Scientific Achievement Award Recipient

Dr. Raymond F. Schinazi, PhD, DSc, Frances Winship Walters Professor of Pediatrics, Director, Laboratory of Biochemical Pharmacology, Senior Research Career Scientist, and Director, Scientific Working Group on Viral Eradication, Emory University Center for AIDS Research

Dr. Schinazi has made extraordinary contributions to science and to human health, particularly for individuals infected with HIV/AIDS, hepatitis B virus (HBV) and hepatitis C virus (HCV). In the early 1980s when scientists realized that AIDS was caused by a virus, Dr. Schinazi set up the first HIV laboratory at Emory and pursued the development of novel antiviral drugs. Four different drugs that his group discovered and developed have been approved by the US Food and Drug Administration for the treatment of HIV-1 infections, as well as three for HBV and one for HCV. It is estimated that over 94% of people infected with HIV take one of his drugs and that his innovative work has saved over 6.5 million lives. His contributions related to HCV are expected to have a profound positive impact on the approximately 170 million people worldwide suffering from chronic infection.

Dr. Schinazi received his BSc (1972) and PhD (1976) in chemistry from the University of Bath, England. He has authored over 500 peer-reviewed papers and 7 books and holds over 92 issued U.S. patents and 120 non-U.S. national stage patents and patent applications, which have resulted in 12 New Drug Applications (NDA). A world leader in nucleoside chemistry, Dr. Schinazi is best known for his pioneering work on HIV and HCV drugs d4T (stavudine), 3TC (lamivudine), FTC (emtricitabine/Emtriva), LdT (telbivudine), and most recently sofosbuvir (Sovaldi), which are now approved by the FDA. Dr. Schinazi is internationally recognized as one of the most influential persons in the life science sector.


Past Recipients

Charles M. Rice, PhD
The Rockefeller University – 2013

Allan W. Wolkoff, MD
Albert Einstein College of Medicine – 2012

Robert H. Purcell, MD
National Institutes of Health – 2011

George K. Michalopoulos, MD, PhD
University of Pittsburgh School of Medicine – 2010

Snorri S. Thorgeisson, MD, PhD
National Cancer Institute, Bethesda, MD - 2009

Neil Kaplowitz, MD
University of Southern California School of Medicine - 2008

Roberto J. Groszmann, MD
West Haven VA Medical Center, West Haven, CT -2006

Nelson Fausto, MD
University of Washington School of Medicine – 2004

Harvey J. Alter, MD
National Institutes of Health – 2002

Nancy L. Bucher, MD
Boston University School of Medicine - 2001

David A. Shafritz, MD
Albert Einstein College of Medicine, Bronx, NY -2000

James L. Boyer, MD
Yale University, New Haven, CT - 1999

Irwin M. Arias, MD
Tufts University School of Medicine, Boston, MA -1998

Francis V. Chisari, MD
The Scripps Research Institute, La Jolla, CA- 1997

Page updated: October 30th, 2014